AUPH
Aurinia Pharmaceuticals
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: AUPH
- PEG Ratio
Aurinia Pharmaceuticals currently trades with a PEG ratio of 0.02, based on Oct 13, 2026 data. Dividing the 6.93 PE ratio by the 436.4% earnings growth rate produces this figure. Relative to the 0.02 average from the past 4 quarters, the PEG ratio has increased by 14%.
AUPH PEG ratio history
Historically, Aurinia Pharmaceuticals maintains a PEG ratio averaging 0.34 across the last two years. At 0.02, today's PEG ratio sits 94% lower than its historical average. The two years high came in the Dec 2024 quarter at 2.09, reflecting peak valuation relative to growth. The bottom was reached in the Dec 2025 quarter at 0, suggesting favorable value relative to growth during that period.
Aurinia Pharmaceuticals PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0 | 7.45 | 5,250% |
| 2024 | 2.09 | 224.5 | 107.4% |
| 2023 | N/A | N/A | 28.9% |
| 2022 | N/A | N/A | 45.7% |
| 2021 | N/A | N/A | -60.9% |
| 2020 | N/A | N/A | 8.4% |
| 2019 | N/A | N/A | -50.8% |
| 2018 | N/A | N/A | 31.5% |
| 2017 | N/A | N/A | -39.4% |
| 2016 | N/A | N/A | -13.8% |
| 2015 | N/A | N/A | 13.4% |
| 2014 | N/A | N/A | -59.5% |
| 2013 | N/A | N/A | 84.6% |
| 2012 | N/A | N/A | N/A |
Aurinia Pharmaceuticals PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 0.02 | 7.19 | 436.4% |
| Mar 2026 | 0.01 | 6.65 | 669% |
| Dec 2025 | 0 | 7.45 | 5,250% |
| Sep 2025 | 0.04 | 19.05 | 514.3% |
| Jun 2025 | 0.08 | 19.25 | 233.3% |
| Mar 2025 | 0.16 | 27.72 | 169% |
| Dec 2024 | 2.09 | 224.5 | 107.4% |
| Sep 2024 | N/A | N/A | 73.6% |
| Jun 2024 | N/A | N/A | 34% |
| Mar 2024 | N/A | N/A | 37.3% |
| Dec 2023 | N/A | N/A | 28.9% |
| Sep 2023 | N/A | N/A | 36.1% |
| Jun 2023 | N/A | N/A | 56.9% |
| Mar 2023 | N/A | N/A | 47.7% |
| Dec 2022 | N/A | N/A | 45.7% |
AUPH average PEG ratio chart
When comparing to historical data, AUPH's PEG ratio comes in under the 3, 5 and 10-year averages.
PEG comparison
Aurinia Pharmaceuticals's PEG of 0.02 is lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.54, Aurinia Pharmaceuticals's PEG is 96% lower.
AUPH EPS growth
AUPH Price vs fair value
AUPH PEG vs peers
Frequently asked questions
What is Aurinia Pharmaceuticals's PEG ratio?
AUPH has a PEG ratio of 0.02, per Oct 13, 2026 data.
What is the 3-year average PEG ratio for Aurinia Pharmaceuticals (AUPH)?
Historical data over a 3-year period puts AUPH's average PEG ratio at 0.34.
What is the 5-year average PEG ratio for Aurinia Pharmaceuticals (AUPH)?
Historical data over a 5-year period puts AUPH's average PEG ratio at 0.34.
What is the highest PEG ratio for AUPH?
The Dec 2024 quarter marked the two years high at 2.09 for AUPH's PEG ratio.
How does the current PEG ratio for AUPH compare to its historical average?
Compared to the 2-year average, AUPH's PEG ratio sits 94% lower.
Why is Aurinia Pharmaceuticals's PEG ratio so low?
Strong earnings growth relative to valuation results in AUPH's low PEG ratio of 0.02.
How is AUPH's PEG ratio calculated (Aurinia Pharmaceuticals PEG ratio formula)?
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth rate (YoY TTM). As of Oct 13, 2026, Aurinia Pharmaceuticals carries a PE ratio of 6.93. Earnings grew at 436.4% over the TTM period ending Jun 2026. Applying the formula, this yields a PEG ratio of 0.02. PEG RATIO(0.02) = PE RATIO(6.93) / EPS GROWTH(436.4%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.